Marché des agents d’embolisation – Analyse des tendances et de la croissance | Année de prévision 2031

  • Report Code : TIPRE00025058
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 219
Buy Now

Le marché des agents d'embolisation devrait atteindre 4 525,75 millions de dollars US d'ici 2028 contre 2 714,82 millions de dollars US en 2021 ; il devrait croître à un TCAC de 7,6 % de 2021 à 2028.



La croissance du marché est attribuée à l'incidence croissante des tumeurs et des anévrismes et à la prévalence croissante de l'hypertension, de l'obésité, du tabagisme et de l'alcoolisme. Cependant, les coûts élevés des agents d'embolisation limitent la croissance du marché des agents d'embolisation. Les agents d'embolisation sont utilisés pour appliquer une occlusion mécanique afin d'arrêter l'écoulement du sang dans un vaisseau sanguin ou une zone vasculaire. En radiologie interventionnelle, l'embolisation est une procédure courante. Les procédures d'embolisation sont principalement utilisées pour traiter les blessures traumatiques. Les agents emboliques se présentent sous diverses formes, chacune avec son propre ensemble de propriétés et d'applications. Selon la durée requise pour l'occlusion artérielle, les agents d'embolisation sont classés comme temporaires ou permanents. La pandémie de COVID-19 a causé des ravages dans les chaînes d'approvisionnement mondiales, les marchés de consommation et les économies. Cette situation a entraîné une baisse des interventions cardiaques pratiquées dans divers pays d'Asie-Pacifique. Les mesures mises en œuvre par les gouvernements du monde entier ont eu un impact négatif sur la croissance du marché des agents d'embolisation. Les tumeurs et les anévrismes alimentent la croissance du marché des agents d'embolisation En 2020, les cancers de la prostate, du poumon et colorectal représentaient 43 % de tous les cancers diagnostiqués chez les hommes. Les cancers du sein, du poumon et colorectal sont les trois cancers les plus fréquemment diagnostiqués chez les femmes. Selon le rapport de la Brain Aneurysm Foundation, Statistics and Facts, aux États-Unis, environ 6,5 millions de personnes, soit 1 personne sur 50, ont un anévrisme cérébral non rompu. Il a également mentionné que 20% du total des personnes diagnostiquées avec un anévrisme cérébral ont plus d'un anévrisme. Il a en outre signalé que, chaque année, environ 30 000 personnes aux États-Unis souffrent d'une rupture d'anévrisme cérébral et qu'une rupture d'anévrisme cérébral se produit toutes les 18 minutes. De plus, selon le NHS, chaque année au Royaume-Uni, 1 personne sur 12 500 a un anévrisme cérébral rompu en Angleterre. En outre, conformément à la ‘Pathogenèse des anévrismes intracrâniens non rompus et prise en charge individualisée’ rapport publié dans Deutsches Ärzteblatt International en 2020, environ 2 millions de personnes (adultes) en Allemagne ont un anévrisme intracrânien (IA) non rompu. Les agents d'embolisation sont utilisés pour arrêter de manière aiguë l'écoulement dans un vaisseau sanguin ou un territoire vasculaire au moyen d'une occlusion mécanique. Les agents embolisants, tels que les microsphères emboliques (billes), sont utilisés pour limiter l'apport vasculaire aux tumeurs et peuvent être chargés de médicaments chimiothérapeutiques, qui éluent et diffusent dans les tissus. Les agents emboliques liquides sont utilisés pour empêcher l'apport sanguin à l'anévrisme ou à la tumeur. Ainsi, la prévalence croissante des anévrismes et des cancers crée une forte demande d'agents d'embolisation.

Insights basés sur les produits



Basé sur le produit, le marché des agents d'embolisation est segmenté en bobines, billes/particules, bouchons, ballons détachables, colle, éponge, liquides emboliques, sclérosants, agents précipitants et autres. Le segment billes/particules détient la plus grande part de marché. Cependant, le segment des bobines devrait enregistrer le TCAC le plus élevé au cours de la période 2021-2028. L'embolisation par bobine est une procédure basée sur un cathéter qui permet une occlusion précise d'un flux sanguin anormal dans un vaisseau sanguin. Le nombre croissant de chirurgies cardiaques propulse la croissance du marché de ce segment.

Marché des agents d'embolisation, par produit - 2021 et 2028



Application - Based Insights



Sur la base des applications, le marché des agents d'embolisation est segmenté en neurologie, oncologie, cardiologie, maladies vasculaires périphériques et autres. Le segment de l'oncologie détient la plus grande part du marché et devrait enregistrer le TCAC le plus élevé du marché au cours de la période de prévision.

Informations basées sur l'utilisateur final



Basé sur l'utilisateur final, le marché des agents d'embolisation est segmenté en hôpitaux, centres chirurgicaux ambulatoires, centres cardiaques et autres. Le segment des hôpitaux détient la plus grande part de marché et devrait enregistrer le TCAC le plus élevé au cours de la période de prévision. La croissance du marché pour ce segment est attribuée au nombre croissant d'hôpitaux à travers le monde et au nombre croissant d'interventions chirurgicales. Les entreprises opérant sur le marché des agents d'embolisation adoptent la stratégie d'innovations de produits pour répondre à l'évolution des demandes des clients à travers le monde, qui leur permet de conserver leur marque sur le marché mondial.

Marché des agents d'embolisation - par produit




  • Bobines
    • Bobines détachables

    • Bobines poussoirs< /li>


  • Perles/ Particules
    • Sphériques

    • Non-sphériques



  • Plugs

  • Ballons détachables

  • Colle

  • Éponge

  • Emboliques liquides

  • Sclérosants

  • Précipitation Agents

  • Autres


Marché des agents d'embolisation - par application




  • Oncologie

  • Neurologie

  • < li>Urologie
  • Cardiologie

  • Maladies vasculaires périphériques

  • Autres


Marché des agents d'embolisation - par utilisateur final


  • Hôpitaux

  • Centres cardiaques

  • Centres de chirurgie ambulatoire

  • Autres


Marché des agents d'embolisation- par géographie




  • Amérique du Nord
    • États-Unis

    • Canada

    • Mexique



  • < li>Europe
    • France

    • Allemagne

    • Italie

    • Royaume-Uni

    • Espagne

    • Reste d'Europe



  • Asie-Pacifique (APAC)
    • Chine

    • Inde

    • Corée du Sud

    • Japon

    • Australie

    • Reste de l'APAC



  • Moyen-Orient et Afrique (MEA)
    • Afrique du Sud

    • Arabie saoudite

    • EAU

    • Reste de la MEA



  • Amérique du Sud et centrale (SCAM )
    • Brésil

    • Argentine

    • Reste de SCAM




Profils des entreprises


  • Medtronic

  • Terumo Corporation

  • Cook Medical LLC

  • Boston Scientific Corporation

  • Abbott

  • < li>Stryker Corporation
  • Penumbra, Inc.

  • Merit Medical Systems Inc.

  • DePuy Synthes

  • KANEKA CORPORATION

  • < /ul>
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are embolization agents?

Embolization agents are used to apply mechanical occlusion to stop the flow of blood in a blood vessel or vascular area. In interventional radiology, embolization is a common procedure. Embolization procedures are most used to treat traumatic injuries. Embolic agents come in a variety of forms, each with its own set of properties and applications. Depending on the duration of time that arterial occlusion is required, embolization agents are classified as temporary or permanent.

What are the driving factors for the embolization agents market across the globe?

The factors that are driving growth of the market are rising incidence of tumors and aneurysms, and growing incidence of hypertension, obesity, smoking, and alcoholism.

Who are the developments carrying out by major players in the embolization agents market?

Various companies have made organic growth strategies in the embolization agents market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as Medtronic, Cook Medical LLC amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.

Which region is dominated the embolization agents market?

North America dominates the global embolization agents market due to factors such as increasing incidences of the neurological disorders such as stroke, brain aneurysms and others across the country, increasing product launches, well-developed healthcare facility centres equipped with modern-age equipment and instruments.

Which segment is growing at the highest CAGR in the embolization agents market?

The coil segment is growing at the highest CAGR owing to increasing number of cardiac surgeries.

Which region is the fastest growing in the embolization agents market?

Asia Pacific is expected to be the fastest growing region in the embolization agents market. The growth of the market in this region is primarily due to factors such as rising prevalence of the brain stroke, coronary artery diseases, heart diseases, increasing surgical procedures, growing number of hospitals and ambulatory surgeries centers, focus by industry players in Japan and developing healthcare infrastructure in India are likely to boost the market growth in forecast period.

The List of Companies - Embolization Agents Market

  1. Medtronic
  2. Terumo Corporation
  3. Cook Medical LLC
  4. Boston Scientific Corporation
  5. Abbott
  6. Stryker Corporation
  7. Penumbra, Inc.
  8. Merit Medical Systems Inc.
  9. DePuy Synthes
  10. KANEKA CORPORATION            

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports